Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)

Spohn, Simon K. B.; Zamboglou, Constantinos; Freitag, Martin T.; Brumberg, Joachim; Engel, Hannes; Gainey, Mark; Kamps, Marius; Toncheva, Paolina; Sprave, Tanja; Kirste, Simon; Sigle, August; Jilg, Cordula; Gratzke, Christian; Adebahr, Sonja; Mix, Michael; Bamberg, Fabian; Zschaeck, Sebastian; Ghadjar, Pirus

Publikationsdienste
→
Universitätsbibliographie
→
8 Zentrale, interfakultäre und fakultätsübergreifende Einrichtungen
→
Dokumentanzeige

« zurück

Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)

Autor(en):

Spohn, Simon K. B.; Zamboglou, Constantinos; Freitag, Martin T.; Brumberg, Joachim; Engel, Hannes; Gainey, Mark; Kamps, Marius; Toncheva, Paolina; Sprave, Tanja; Kirste, Simon; Sigle, August; Jilg, Cordula; Gratzke, Christian; Adebahr, Sonja; Mix, Michael; Bamberg, Fabian; Zschaeck, Sebastian; Ghadjar, Pirus

Tübinger Autor(en):

Zschaeck, Sebastian
Ghadjar, Pirus

Erschienen in:

Radiotherapy and Oncology (2025), Bd. 208, Article 110883

Verlagsangabe:

Clare : Elsevier Ireland Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.radonc.2025.110883

ISSN:

0167-8140